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Background: Mammalian-wide interspersed repeats (MIRs) are the most ancient family of transposable elements
(TEs) in the human genome. The deep conservation of MIRs initially suggested the possibility that they had been
exapted to play functional roles for their host genomes. MIRs also happen to be the only TEs whose presence
in-and-around human genes is positively correlated to tissue-specific gene expression. Similar associations of
enhancer prevalence within genes and tissue-specific expression, along with MIRs’ previous implication as providing
regulatory sequences, suggested a possible link between MIRs and enhancers.
Results: To test the possibility that MIRs contribute functional enhancers to the human genome, we evaluated the
relationship between MIRs and human tissue-specific enhancers in terms of genomic location, chromatin
environment, regulatory function, and mechanistic attributes. This analysis revealed MIRs to be highly concentrated
in enhancers of the K562 and HeLa human cell-types. Significantly more enhancers were found to be linked to MIRs
than would be expected by chance, and putative MIR-derived enhancers are characterized by a chromatin
environment highly similar to that of canonical enhancers. MIR-derived enhancers show strong associations with
gene expression levels, tissue-specific gene expression and tissue-specific cellular functions, including a number of
biological processes related to erythropoiesis. MIR-derived enhancers were found to be a rich source of transcription
factor binding sites, underscoring one possible mechanistic route for the element sequences co-option as
enhancers. There is also tentative evidence to suggest that MIR-enhancer function is related to the transcriptional
activity of non-coding RNAs.
Conclusions: Taken together, these data reveal enhancers to be an important cis-regulatory platform from which
MIRs can exercise a regulatory function in the human genome and help to resolve a long-standing conundrum as
to the reason for MIRs’ deep evolutionary conservation.Background
Transposable elements (TEs) are abundant in eukaryotic
genomes, particularly mammalian genomes. Indeed, at least
45% of the human genome is made up of TE-derived se-
quences [1,2], which are non-randomly distributed across
the genome. For example, human Alu short interspersed
elements (SINEs) are predominantly found in GC- and
gene-rich regions, whereas L1 long interspersed elements
(LINEs) are most prevalent in low-GC and gene-poor* Correspondence: king.jordan@biology.gatech.edu
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reproduction in any medium, provided the orregions [1,3]. Transposable elements have also been shown
to affect the expression of host genes via the provisioning
of a variety of regulatory sequences [4]. The non-random
genomic distribution of human TEs, considered together
with their regulatory potential, initially suggested the possi-
bility that the TEenvironment of human genes might affect
the way that they are expressed.
In fact, a number of associations between the TE environ-
ment in-and-around human genes and their expression
levels and functional patterns have subsequently been ob-
served. Weakly expressed genes generally contain low SINE
and high LINE densities, while the most highly expressed
human genes are enriched for SINEs (Alu) [5] and depletedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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cantly associated with the breadth of gene expression across
tissues [7,8]. Thus, highly and broadly expressed house-
keeping genes are identifiable by their TE-content, which
is rich in Alus and poor in L1s [9]. Functionally, TEs have
recently been demonstrated to have been exapted during
the evolution of novel phenotypic characteristics, such as
mammalian pregnancy [10,11]. Mammalian-wide inter-
spersed repeats (MIRs) are the only TEs that show a posi-
tive association between their prevalence in-and-around
genes and tissue-specific gene expression [8,12].
MIR elements are an ancient family of tRNA-derived
SINEs [13,14], whose anomalous sequence-conservation
levels among mammalian genomes were initially taken
as evidence that they encode some unknown regulatory
function [15]. Succeeding studies demonstrated that,
in a number of individual cases, MIRs do in fact donate
transcription-factor binding sites [16-20], enhancers
[18,21,22], microRNAs [23,24] and cis natural antisense
transcripts [25] to the human genome. The association
of MIRs with tissue-specific expression, along with
their propensity to be exapted as regulatory sequences,
suggests to us the possibility that they might provide
numerous tissue-specific regulatory sequences across
the human genome [8].
Enhancers are regulatory elements that are most highly
associated with tissue-specific expression [26,27]. They are
also characterized by a unique chromatin environment
made up of a specific combination of histone modifica-
tions [26-29]. Consistent with their role as tissue-specific
regulatory elements, the enhancer chromatin environment
is highly variable across cell-types, compared to other clas-
ses of regulatory sequences [26,27,29]. We hypothesized
that the global coincident association of both MIRs and
enhancers to tissue-specific gene expression is at least
in part a consequence of MIR sequences frequently act-
ing either as enhancers and/or constituting fragments of
enhancer sequences. This would be consistent with
previously reported individual cases of TE-derived en-
hancers [21,30-32]. We also reasoned that the enhancer-
characteristic chromatin environment could serve as a
useful proxy to identify putative MIR-derived enhancers.
To test our hypothesis, we performed a genome-wide
assessment of the relative prevalence of MIRs within en-
hancer sequences and explored the potential mechanistic
bases and functional consequences of this relationship.
We found that not only are MIRs highly concentrated in
predicted enhancers, but they also constitute a significant
part of the core of genic enhancers; this analysis identified
many more putative MIR-derived enhancers than previ-
ously reported [22,33]. These MIR-derived enhancers have
cell-type specific chromatin profiles that are highly similar
to those seen for canonical enhancers. Furthermore, we
report MIRs to be major donors of transcription-factorbinding sites (TFBSs) within enhancers, and show that
MIR-derived enhancers affect both the level and tissue-
specificity of gene expression. Using the erythroid K562
cell-line as an example, we show that MIR-enhancers are
involved in the modulation of several developmentally-
specific biological processes related to erythropoiesis.
Results and discussion
MIRs are highly concentrated in enhancers
As noted in the introduction, MIRs are the only TEs
that show a positive association with tissue-specific
gene expression [8]. Similarly, unlike other cis-regulatory
elements, enhancers are marked with highly cell-type
specific histone modification patterns [26] and are accord-
ingly also highly related to tissue-specific gene expression
[26,27]. We thus sought to test our working hypothesis that
these apparent similarities between MIRs and enhancers
are largely a consequence of MIR sequences either fre-
quently acting as enhancers and/or constituting fragments
of enhancer sequences.
The genomic coordinates of 24,538 and 36,550 putative
transcriptional enhancers in the K562 and HeLa cell-lines,
respectively, [26] were intersected with those of all 593,339
MIRs in the genome. For all genomic enhancers, we
computed the fraction of MIRs in and around 20 kb
loci centered on all genomic enhancers (n = 24,538 and
36,550 for K562 and HeLa cell-lines respectively) and
compared it with MIR enrichment in the local genomic
background. The results reveal MIRs to be highly
enriched within all enhancers genome-wide, with up
to ≈ 26% and ≈ 27% more MIRs within enhancers than
in the genomic background for K562 and HeLa cell-lines
(χ2 = 4592, P < 1.0 × 10 -308, K562; χ2 = 7470, P < 1.0 × 10-308,
HeLa; Figure 1A and Additional file 1: Figure S1A).
The overall distribution of MIRs within enhancers
reveals more than 74% of enhancers to contain MIRs
(Additional file 1: Figure S1D). Furthermore, MIRs
show a significantly higher concentration within enhancers
relative to all other TEs (Figure 1B). Additionally, the
locations of 19,536 Refseq gene annotations [8] were
also intersected with those of enhancers. This yielded
1,917 and 2,090 genes with predicted enhancers in
their gene bodies in the K562 and HeLa cell-lines. For
each of these genes, its resident enhancers and its non-
enhancer sequences were intersected with a set of all
genomic MIRs from the University of California Santa
Cruz (UCSC) Genome Browser [34,35], yielding MIR
densities within both genic enhancers and genic non-
enhancer regions. Within gene bodies, MIRs show signifi-
cantly higher densities in enhancers than in non-enhancer
sequences (Figure 1C and Additional file 1: Figure S1B).
Furthermore, MIRs are vastly overrepresented components
of the core 200 bp of genic enhancers, showing eight-




























































































Figure 1 MIRs are highly concentrated within enhancers. (A) Fold enrichment of MIRs in-and-around all genic enhancers (red) and intergenic
enhancers (green) relative to the local genomic background (gray). (B) Average difference between transposable element densities around
enhancers and around genomic background. (C) Average MIR densities for genic enhancers compared to genic background in K562
(significance level computed using the paired t test). (D) Average (±standard error) densities of MIRs in the core 200 bp of genic enhancers (white bar)
versus the corresponding non-enhancer sequences of the same genes (gray).
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K562 and HeLa cell-lines (Figure 1D and Additional file 1:
Figure S1C).
Thus, while MIRs have been previously reported to be
enriched within introns [12], our data clearly reveal this
genic enrichment to be strongly biased towards enhancers.
And while MIRs are known to donate enhancers in a
number of individual cases [21,22,33], these data show an
even deeper relationship, namely that MIRs are substan-
tially concentrated in enhancers genome-wide.
Numerous MIRs provide enhancers or are linked
to enhancers
Finding MIRs to be highly concentrated within enhancers,
we sought to establish the numbers and locations of
MIRs that provide core enhancer sequences themselves
(MIR-enhancers) as well as those that lie within enhan-
cer regions (enhancer-MIRs). We found 934 and 1,429
MIRs to be MIR-enhancers in K562 and HeLa cell-lines
(genomic locations in Additional file 2). This is in contrast
to the 669 and 996 MIRs that would be expected to be
enhancers in the two cell-lines if MIRs were randomly
distributed among enhancers (χ2 = 105, P = 1.2 × 10-24,K562; χ2 = 188, P = 1.0 × 10-42, HeLa). Furthermore, the
numbers of MIR-derived enhancers identified here is
far greater than has been previously reported [22,33],
owing to the availability of more enhancer annotations
and a more accurate estimate of the size of enhancers,
which we deduced from the span of characteristic enhancer
histone-modifications at enhancer sites. When this ana-
lysis was expanded to include all enhancer-linked MIRs
(that is, enhancer-MIRs), the extent to which enhancers
are connected to MIRs became even more apparent. We
found 16,144 and 26,520 enhancers to be linked to MIRs in
K562 and HeLa celllines respectively, compared with
the 6,559 and 9,320 enhancer-MIRs that would be ex-
pected by chance alone (χ2 = 14,007, P < 1.0 × 10-308, K562;
χ2 = 31,742, P < 1.0 × 10-308, HeLa).
We compared the chromatin (histone modification)
environment of MIRenhancers and enhancer-MIRs with
canonical predicted enhancers to further evaluate their
status as enhancers and their regulatory potential. The
histone modifications H3K4me1 and H3K27Ac have been
shown to be enriched at experimentally characterized
enhancers in a number of studies [26,29,36,37]. We
found both MIR-enhancers and enhancer-MIRs to
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similar to those of canonical predicted enhancers in
K562 and HeLa cells (Figure 2 and Additional file 1:
Figure S2A-E). However, the order of histone modification
congruity is tissue-specific, with H3K4me1 showing the
highest congruity in K562 (Figure 2D and Additional file 1:
Figure S3) and H3K27ac with the highest congruity in HeLa
(Additional file 1: Figure S3). Also, the repressive mark
H3K27me3 shows the least congruity (Additional file 1:
Figure S3A) and is, in fact, deleted at both MIR-enhancers
and enhancer-MIRs (Additional file 1: Figure S2E, F). As
expected, enhancer-MIRs show a somewhat diminished
enrichment and congruity of these two modifications,
since this category includes enhancer-linked MIRs rather
than MIR-enhancers that lie at the core of enhancers.
Interestingly, MIR-enhancers show a significantly stronger
enrichment of the enhancer distinguishing modifications













































Figure 2 The chromatin environment of MIR-enhancers is similar to tha
centered on (A) canonical enhancers and (B) MIR-enhancers. (C) Congruence
enhancers and MIR-enhancers. (D) Rank order of correlations of histone modi
MIR-enhancers weighted by slope.enhancers (P = 6.9 × 10-14, K562; 9.6 × 10-24, HeLa, paired
t test for the two modifications).
MIRs are enriched for TFBSs
Enhancers are known to boost gene expression by recruit-
ing transcription factors (TFs), which in turn interact with
promoters to recruit RNA polymerase II, facilitating
the initiation of transcription [38]. Accordingly, a plausible
evolutionary route for the exaptation of MIRs into en-
hancers would be that MIRs offered a rich source of
TFBSs compared with random genomic sequences. We
investigated this possibility by exploring the contribu-
tion of enhancer-associated MIRs (MIR-enhancers and
enhancer-MIRs) to TFBS sequence motifs corresponding to
several TFs that are known to be active in K562-specific
cellular processes: C-JUN, NF-E2, and ZNF274 [39-42].
TFBS sequence motifs for C-JUN and NF-E2 are found in
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same fraction of the genome. This is the case when motifs
are counted using position weight matrices (PWMs) of
the TFBS [43] (Figure 3A) or the regular expression
representations of the TFBS (Additional file 1: Figure S4A
and Table S1A). The PWM method [44] additionally
yielded factors Elf-1, SF-1, and LRH-1 as enriched in
enhancer-MIRs (P values of 2.7 × 10-2, 7.2 × 10-3, and
1.3 × 10-3 respectively). We also surveyed experimentally
characterized occupancy of enhancer-associated MIRs by
these same TFs using ChIP-seq (chromatin immunopre-
cipitation followed by high-throughput sequencing) data
from the ENCODE project. Transcription-factor binding
characterized in this way confirms that C-JUN and NF-E2
occupancy levels are > nine-fold higher, while ZNF274
is also enriched, albeit marginally, within enhancer-
associated MIRs relative to non-enhancer-associated
MIRs in the K562 cell-line (Figure 3B). Similar analyses
conducted with additional TFBSs corresponding to
TFs with binding experimentally characterized in K562
also revealed enrichments of TFBS sequence motifs and
TF bound sites in enhancer-associated MIRs. Enrichment
of TF binding at enhancer-associated MIRs was observed
for 37/39 and 37/44 bound TFs in K562 and HeLa cells,
respectively (Additional file 1: Figure S4B). Finally, these
two data types were integrated by evaluating the presence
of canonical TFBS sequence motifs among the set of






























Figure 3 TFBS presence and TF binding in enhancer-associated MIRs.
(blue) compared with random genomic sequences (gray) (significance leve
enhancer-associated MIRs relative to non-enhancer-associated MIRs in K562be bound by the TFs C-JUN, NF-E2, and ZNF274. Consist-
ent with previous ChIP-seq studies [45], not all enhancer-
associated MIRs that are experimentally characterized to
be bound by TFs show canonical TFBS sequence motifs.
Nevertheless, numerous MIR-derived enhancer sequences
can be seen to provision TFBS sequence motifs for these
TFs in K562 (Figure 4). Taken together, these data are
consistent with the notion that the evolutionary co-option
of MIRs into enhancers is due in part to their relatively
large and functionally relevant repertoire of TFBSs.
Enhancer-associated MIRs influence gene expression
levels and tissue-specificity
To check whether the observed prevalence and TF
binding capacity of enhancer-associated MIRs trans-
lates into genome-wide regulatory effects, we related
enhancer-associated MIR densities to two gene expression
parameters: gene expression level and tissue-specificity. For
both K562 and HeLa cell-lines, the density of enhancer-
associated MIRs in and around genes is significantly related
to gene expression levels (Figure 5A and Additional file 1:
Figure S5A). Similarly, there are significant relationships
between enhancer-associated MIR densities in both K562
and HeLa cell-lines and tissue-specific expression across 6
ENCODE cell-lines (Figure 5B and Additional file 1: Figure
S5B,D). The relationship between enhancer-associated MIR
density and tissue-specific expression is even more appar-







































(A) Number of TFBS sequence motifs in enhancer-associated MIRs
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Figure 4 TFBS sequence motifs for TF bound enhancer-associated MIRs. (A) Data for TFBS sequence motifs present in TF bound
enhancer-MIRs. (B) Examples of TFBS sequence motifs for C-JUN and ZNF274 present in individual TF bound enhancer-associated MIR sequences.
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Figure 5 Effect of enhancer-associated MIRs on gene expression. (A) Relationship between density of enhancer-MIRs and gene expression
levels in K562. (B) Relationship between density of K562 enhancer-MIRs and tissue-specificity of gene expression across six ENCODE cell-lines.
(C) Relationship between density of K562 enhancer-MIRs and tissue-specificity of gene expression across 79 tissues from the Norvatis Gene
Expression Atlas. Pearson correlation coefficient values (r) along with their significance values (P) are shown for all pairwise regressions. (D) Relative
strength of correlation between the densities of different TE types around genes and the tissue-specificity of those genes.
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[46] (Figure 5C and Additional file 1: Figure S5C,E).
That relationship holds even when tissue-specificity is
calculated using Shannon entropy [47] (Additional file 1:
Figure S5D,E) and is substantially stronger for MIRs
relative to other TEs (Figure 5D). Moreover, this rela-
tionship with tissue-specificity is independent of local
genomic context as measured by GC content of the
TEs (Additional file 1: Table S1C). Furthermore, the
number of MIR-derived TFBS in the 5% most tissue-
specific genes was ≈ 25% higher than that for the 5% least
tissue-specific genes. Taken together, these data reveal
enhancer-associated MIRs to have a significant association
with the genome-wide patterns of gene expression levels
from the cell-lines in which the enhancers were identified,
as well as the overall tissue-specificity measured across
multiple cell-lines and tissues.
Functional significance of enhancer-associated MIRs
Since enhancer-associated MIRs are related to tissue-
specific gene expression, it is reasonable to expect that
there are some tissue-specific biological functions that
they may help to regulate. We examined this prospect
in the K562 cell-line by assessing the functional roles of
genes within 100 kb of tissue-specific enhancer-associated
MIRs. Of 19,538 non-overlapping Refseq genes, we found
3,798 (19.5%) to be associated with such K562 predicted
enhancer-associated MIRs. We tested for relative enrich-
ment of those genes within a set of 350 genes that have
been shown to be highly regulated in erythroids across
four stages of erythropoiesis [48]. Of the 3,798 enhancer-
associated MIR associated genes, 202 overlapped the set
of 350 genes that are highly regulated in erythropoiesis or
their close homologs. This overlap is highly significant
(hypergeometric test, P = 2.1 × 10-57) and suggests that
enhancer-associated MIRs might have an impact on
erythropoietic regulation. We therefore broadened the
analysis to include other biological processes related to
erythropoiesis. We tested for enrichment of enhancer-MIR
associated genes in gene sets of nine erythroid biological
functions obtained from the Broad Institute’s molecular
signatures database (MSigDB). Gene sets for eight out of
the nine erythroid-related biological functions are signifi-
cantly enriched among enhancer-associated MIR-linked
genes (Figure 6A and Additional file 1: Table S2). These
results were further supported by functional analysis of
our enhancer-associated MIRs using the GREAT tool [49].
The biological processes it identified are highly similar
to those identified previously, including erythropoiesis
and its related functions, such as myeloid cell differen-
tiation, interphase of mitotic cell cycle and homeosta-
sis of a number of cells.
To further understand the impact that enhancer-
associated MIRs might have on K562 cell-type specificbiological functions, we focused on the erythropoiesis
biological function, whose gene set has the most significant
overlap with enhancer-MIR associated genes (Figure 6A).
This gene set contains genes that have been implicated
in various aspects of erythrocyte function and development
[50]. We compared the expression levels of enhancer-MIR
associated genes in this gene set with developmental
stages of erythropoiesis and found them to have highly
divergent expression levels across development, an indi-
cator that enhancer-associated MIRs might be involved
in their regulation during erythropoiesis (Figure 6B and
Additional file 1: Table S3).
Interestingly, this erythropoiesis gene set and its related
enhancer-associated MIRs include four distinct MIR se-
quences that were previously implicated as being involved
in the regulation of the α-globin gene cluster by virtue
of their co-location with an experimentally characterized
‘locus control region’ [51]. This cluster contains a number
of globin genes, including HBZ and HBA1, both of which
are enhancer-MIR associated and differentially expressed
across the various stages of erythropoiesis (Figure 6B,C).
Furthermore, the enhancer-associated MIRs in the locus
control region can be seen to be marked by the enhancer-
related histone modifications H3K4me1 and H3K27ac, to
recruit the TFs C-JUN, NF-E2 and ZNF274, and to reside
in a relatively open chromatin environment, as character-
ized by DNase I hypersensitive sites (DHSs) (Figure 6C). In
addition, one of the four locus control region co-located
MIRs appears to recruit RNA polymerase II (Pol2) tran-
scriptional machinery. This suggests the possibility that
enhancer-associated MIRs might also exert their regula-
tory activity by virtue of the transcriptional activity of
non-coding RNAs, as has been observed for a number
of TE- and tRNA-derived regulatory sequences [52-54].
Consistent with this possibility, non-coding RNA tran-
scriptional activity has been suggested as a widespread
mechanism underlying enhancer function in mammalian
genomes [55-58].
Considered together, these results suggest that K562-
predicted enhancer-associated MIRs are active in the
cell-type specific and developmental regulation of genes
involved in a number of biological processes related to
K562 functions in general, and erythropoiesis in particular.
Furthermore, the exaptation of MIRs as enhancers might
be predicated upon the recruitment of specific TFs, as pre-
viously discussed, as well as the transcriptional activity of
non-coding RNAs.
Conclusions
A number of previous studies have found different classes
and families of TEs and TE-derived sequences to have
distinct and substantial effects on genome regulation
[4]. In one such study [8], our group identified MIRs to be
the only TE-derived sequences whose presence shows a
AC
B
Figure 6 Functional enrichment of enhancer-associated MIR-linked genes in erythropoiesis. (A) Enrichment levels of enhancer-associated
MIR-linked genes within gene sets for erythropoiesis-related biological functions. Statistical significance (P values computed using the hypergeometric test).
(B) Enhancer-MIR associated gene sets (colored boxes) that are dynamically expressed across developmental stages of erythropoiesis.
(C) Enhancer-associated MIRs (red) in the α-globin gene cluster locus control region (LCR, green). Locations of histone modifications, TF and Pol2 binding,
DNase I hypersensitive sites (DHSs) are shown.
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Here, we provide evidence that this correlation is likely
to be due to the propensity of MIRs to be exapted as
enhancers that regulate cell-type and developmental-stage
specific gene expression. We show that MIR-relatedenhancer activity is functionally relevant and may be
related to TF binding, as well as the transcriptional activity
of non-coding RNAs. The widespread exaptation of previ-
ously selfish MIR sequences as enhancers resolves a
long-standing conundrum arising from the observation
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served to be simply non-functional or ‘junk’ DNA [15].
Methods
Identification of MIR-related enhancers
We used two sets of 24,538 and 36,550 putative transcrip-
tional enhancers, predicted in the K562 and HeLa cell-
lines, respectively [26]. These enhancers were predicted as
ENCODE regions that bear specific chromatin histone
modification (H3K4me1 and H3K27ac) profiles that are
similar to those seen for genomic regions bound by the
coactivator protein p300, which is known to colocalize
at active enhancers [59]. The p300 binding sites were
themselves located using a chromatin immunoprecipitation-
based microarray method (ChIP-chip) and the histone
modification data were taken from the ENCODE pro-
ject [36,60]. We considered the span of enhancers to
be the ±4 kb region around the predicted enhancer
midpoints, which corresponds roughly to the empiric-
ally determined range of the characteristic chromatin
pattern found at predicted enhancers (Figure 2A). We
intersected the coordinates of these enhancers with the
RepeatMasker [3] annotations of MIR elements as identi-
fied by the Repbase classification system [61,62] to predict
MIR-related enhancers. These MIR annotations on the
human genome assembly (NCBI build 36.1; UCSC hg18)
were downloaded from the UCSC Genome Browser
[34,35]. Each putative enhancer analyzed here was ori-
ginally predicted to be anchored around a single base-
pair position [26]. If this core basepair was located in a
MIR, then such a MIR was classified as a core enhan-
cer. Such cases are considered MIR-enhancers for the
purposes of analysis. On the other hand, some MIRs
do not donate the core enhancer locus but are instead
located within the typical ±4 kb span for enhancers.
These MIRs were considered enhancer-linked MIRs
and are referred to as enhancer-MIRs. There are thus
two categories of MIR-related enhancers analyzed here:
MIR-enhancers and enhancer-MIRs. However, at both the
locational and functional levels, both categories of MIRs
are part of the enhancer body, which we determined using
the span of its chromatin profile.
A set of 19,536 non-overlapping transcriptional units
derived from Refseq gene annotations, as defined in
reference [8], was used to assess MIR densities within
genes. For both the K562 and HeLa cell-lines, regions
of overlap between MIR genomic coordinates and four
different types of genomic elements or regions were
determined: (i) genic enhancers, (ii) genic non-enhancer
regions, (iii) non-genic enhancers, and (iv) the core 200 bp
region around predicted enhancer midpoints. For each
region, the density of MIRs was computed either as the
fraction of the length of each region in basepairs that
was occupied by MIRs or their fold enrichment withinthe regions relative to the local genomic background.
The local genomic backgrounds were compiled as re-
gions randomly sampled 100 kb downstream of each
locus of interest. Their enrichment in terms of MIRs or
other ChIP-seq datasets was then divided by the average
densities of those datasets over the entire genome to obtain
their normalized signal values.
Expected numbers of MIR-enhancers were com-
puted as the average genome-wide density of enhancers
(enhancers/bp) multiplied by the total length in basepairs
of all genomic MIRs. Expected numbers of enhancers with
MIRs were simulated by mapping random genomic sites
equivalent to MIRs (in number and size) to enhancer
regions and then counting the number of enhancers that
were overlapped.
Histone modification profile analysis
Genome-wide ChIP-seq [63] data for eight histone
modifications (H3K4me1, H3K27ac, H3K36me3, H3K9ac,
H3K4me2, H3K4me3, H4K20me1, and H3K27me3) in
the K562 and HeLa-S3 cell-lines was taken from the
‘ENCODE histone modification tracks’ of the UCSC
Genome Browser. Genomic loci of 20 kb centered on ca-
nonical enhancers (all predicted enhancers), MIR-enhancers,
and enhancer-MIRs were evaluated for enrichment of the
histone modifications. Counts of each histone modification
within 500 bp windows across the 20 kb region were then
computed and their profiles represented as fold enrich-
ments relative to average counts per 500 bp in the genomic
background. The congruence of histone modification
profiles between canonical enhancers and MIR-related
enhancers was assessed using rank correlations between
modification enrichments, which were weighted by the
slope of their line-of-best-fit to establish the relative order
of histone mark enrichment congruence.
Transcription-factor binding site analysis
TFBS sequence motifs within MIR-related enhancers
were identified using both PWMs and regular expres-
sion representations of sequence motifs corresponding
to K562-related TFs as gleaned from the experimental
literature and TF databases [45,64-68]. Counts of TFBS
sequence motifs in MIR-related enhancer sequences
were compared with counts of the same motifs in random
genomic sequences of the same number and size. For each
transcription factor, we obtained the expected number by
counting the number of motifs in 1,000 random samples,
each being of the same size as the enhancer-MIR set
(50,599 sequences). The medians of those distributions
were then considered the expected number for each motif.
P values were then empirically determined using a Z test
on the distributions with μ the median and χ the observed
number of motifs in enhancer-MIRs, which is the same
number as our set of enhancer-associated MIRs.
Jjingo et al. Mobile DNA 2014, 5:14 Page 10 of 12
http://www.mobilednajournal.com/content/5/1/14Experimentally characterized TF binding sites within
MIR-related enhancer sequences were identified using
ChIP-seq data from the ‘ENCODE transcription-factor
binding tracks’ of the UCSC Genome Browser. Enrichment
values of TF occupancy levels for MIR-related enhancer
sequences were computed using ChIP-seq tag counts
within MIR-related sequences normalized by the genome
average ChIP-seq tag counts for non-enhancer-MIRs.
The presence of TFBS sequence motifs within ChIP-seq
characterized TF bound regions was evaluated using regu-
lar expressions, as described, along with the motif finding
program MEME [69].
Gene expression analysis
Two sets of gene expression data were used here. The
first dataset of exon microarray data for six ENCODE
cell-lines (K562, HeLa-S3, GM12878, HepG2, H7Hesc,
and HUVEC) was taken from the ‘ENCODE exon array’
track of the UCSC Genome Browser. Exon array data
were converted into gene expression levels for 18,654
genes as outlined in reference [70]. The second dataset
of Affymetrix microarray expression data from 79 tissues
and cell-lines was taken from the Norvatis Gene Expression
Atlas [71]. Signal intensity values for individual probes from
this dataset were normalized and associated with 15,658
genes, as previously outlined [8]. For both datasets, a
tissue-specificity index (TS) for each gene was computed





where N is the number of tissues and xi represents a
gene’s signal intensity value in each tissue i divided by
the maximum signal intensity value of the gene across
all tissues. For both datasets, tissue-specificity was also
calculated based on the entropy among gene expres-
sion levels between tissues using Shannon entropy [47]
in R’s Bioconductor package.
For each gene, the density of enhancer-associated MIRs
in and around the gene (from 10 kb upstream to 10 kb
downstream) was computed by dividing the number of
enhancer-associated MIRs in that genomic range by the
number of base pairs in the range. The density values of
the enhancer-associated MIRs were then divided into
100 equal bins whose average densities were regressed
against the respective average expression levels or TS of
the associated genes.
Functional association analysis
The functional effects of enhancer-associated MIRs
were evaluated using erythroid (K562)-specific enhancer-
associated MIRs (defined as enhancer-associated MIRs
present in K562 and absent in HeLa). Genes were associatedwith K562-specific enhancer-associated MIRs within 100 kb.
The hypergeometric test was used to check for enrichment
of enhancer-MIR associated genes within (i) a set of 350
genes previously shown to be developmentally regulated
in erythroids across four stages of erythropoiesis [48], and
(ii) gene sets for nine erythroid-related cellular functions
(Additional file 1: Table S1) taken from the Broad Institute’s
molecular signatures database (MSigDB). Developmental
regulation of enhancer-MIR associated erythropoiesis-
related genes was assessed using gene expression data
for five stages of erythrocyte development [50].
Additional files
Additional file 1: Figures S1-S5 and Tables S1-S3. MIRs regulate
human gene expression and function predominantly via enhancers.
Additional file 2: Genomic loci of MIR-derived enhancers in K562
and HeLa cell-lines.
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